Keywords: Ethris, Shire, RNA-based therapeutics, Genetic diseases, Research collaboration

Ethris enters SNIM modified RNA alliance with Shire

Article | 07 January 2013

Print This

German biotech firm Ethris GmbH has initiated a research based alliance focused on the development and commercialization of novel RNA-based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in